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T
here is a well-documented 
relationship between short sleep 
duration and high body mass 
index (BMI). In the largest study, a 
survey on sleep duration and frequency 
of insomnia in more than 1.1 million 
participants, increasing BMI occurred 
for habitual sleep amounts below 7–8 
hours [1]. A recent prospective study 
found an association between sleep 
curtailment and future weight gain 
[2]. The mechanism linking short 
sleep with weight gain is unknown, but 
Mignot and colleagues’ study in this 
month’s PLoS Medicine [3] adds to the 
growing evidence implicating leptin 
and ghrelin, the two key opposing 
hormones involved in appetite 
regulation.
Hormones That Regulate Appetite
Leptin, a peptide hormone secreted 
from white adipocytes, is implicated 
in the regulation of food intake and 
energy balance. The hormone acts on 
the central nervous system, in particular 
the hypothalamus, suppressing 
food intake and stimulating energy 
expenditure. Leptin production is 
primarily regulated by insulin-induced 
changes in adipocyte metabolism—its 
secretion levels correlate with adipocyte 
mass and lipid loads.
Leptin promotes inﬂ  ammation. The 
hormone provides an interesting link 
between obesity and pathophysiological 
processes such as insulin resistance 
and atherosclerosis, and disorders such 
as autoimmune and cardiovascular 
diseases and the metabolic syndrome. 
Increased serum leptin levels in obesity 
and metabolic syndrome support 
the view that these disorders are in 
fact low-grade systemic inﬂ  ammatory 
diseases, characterized by increased 
concentrations of proinﬂ  ammatory 
cytokines like interleukin-6, tumor 
necrosis factor-α, and leptin. Leptin’s 
proinﬂ  ammatory role suggests that it 
may link energy homeostasis to the 
immune system [4,5].
Ghrelin is a peptide hormone that 
stimulates appetite, fat production, 
and body growth—leading to increased 
food intake and body weight. It is 
secreted into the circulation from the 
stomach, but is also synthesised in a 
number of other tissues, including the 
kidney, pituitary, and hypothalamus, 
suggesting that the hormone has 
both distant and local (endocrine 
and paracrine) effects. These effects 
include stimulating the secretion 
of growth hormone, prolactin, and 
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adrenocorticotropic hormone, and a 
diabetogenic effect on carbohydrate 
metabolism [6].
The New Study
In this study of 1,024 participants 
in the population-based Wisconsin 
Sleep Cohort Study [7], Mignot and 
colleagues found that in persons 
sleeping less than 8 hours, increased 
BMI was proportional to decreased 
sleep [3]. The researchers also found 
that shorter sleep times were associated 
with increased circulating ghrelin and 
decreased leptin, a hormonal pattern 
that is consistent with decreased energy 
expenditure and increased appetite 
and obesity.
These ﬁ  ndings conﬁ  rm earlier 
clinical reports on the effects of 
sleep deprivation and extend them 
to include naturalistic sleep in a 
large, community-based population. 
The study provides an exciting 
addition to the growing literature 
showing relationships between sleep 
curtailment, metabolic hormones, 
and metabolic disorders (including 
obesity). The data have important 
implications for our understanding of 
obesity and related disorders in the 
general population, with one caveat: 
the study population was enriched 
with snorers, making the results less 
applicable to a general population.
Mignot and colleagues’ data are 
in accord with human and animal 
studies that show that experimental 
curtailment of sleep leads to lower 
levels of leptin [8,9,10,11] and 
increased ghrelin [12]. The new study 
therefore lends some support to the 
interpretation that reduced sleep levels 
cause the hormonal changes. 
But there is also evidence of opposite 
effects—that is, that administration of 
leptin [13] and ghrelin can alter sleep. 
Ghrelin administration has been found 
to increase non-REM sleep in humans 
and mice, possibly via its interactions 
with the sleep-inducing peptide growth 
hormone releasing hormone (GHRH). 
Ghrelin is an endogenous ligand of 
the growth hormone secretagogue 
receptor, making it a candidate for an 
endogenous sleep-promoting factor 
[14]. Mignot and colleagues’ study is 
congruent with the idea that inadequate 
sleep enhances ghrelin secretion, which 
in turn acts as an endogenous sleep 
factor in humans. This is an important 
new area of research that could 
conceivably lead to more physiological 
sleep aids than are currently available, 
with profound implications for 
improved public health.
Overall, the available studies suggest 
the presence of reciprocal interactions 
between metabolic hormones and sleep, 
relationships that are poorly understood 
at present. Does sleep interact with 
metabolic hormones directly or via 
intervening factors such as sleep-related 
breathing disorders? Patients with 
obstructive sleep apnea have impaired 
sleep and higher ghrelin levels than 
BMI-matched controls, and treatment 
with continuous positive airway pressure 
reduces ghrelin to control levels [15]. 
Although sleep-disordered breathing 
(SDB) was measured in the present 
study, the SDB analyses were not shown, 
making it difﬁ  cult to evaluate the 
inﬂ  uence of SDB on ghrelin and leptin 
in this population.
There is a clear need for well-
controlled, population-based studies 
that allow us to examine multiple 
relevant factors simultaneously. 
The present study highlights the 
importance of shortened sleep in 
relation to obesity, leptin, and ghrelin, 
a good start toward this goal. 
Sleep and Public Health
Many other important questions 
remain, such as the roles that 
other hormones, cytokines, and 
SDB play in obesity. Many of the 
unanswered questions have important 
implications for public health. For 
example, diabetes, visceral obesity, 
hypertension, and hyperinsulinemia 
commonly aggregate together in 
large populations, and are considered 
a “metabolic syndrome” that has 
been linked to SDB [16] and to 
inﬂ  ammatory disorders [17]. To 
what extent does long-term sleep 
curtailment contribute to these and 
related public health issues? 
The possible role of sleep restriction 
in autoimmune and inﬂ  ammatory 
disorders is of particular interest in 
light of recent ﬁ  ndings linking immune 
function with ghrelin and leptin. 
Ghrelin and its receptor are expressed 
in human T-lymphocytes, where 
they can inhibit cytokine activation, 
including interleukins, tumor necrosis 
factor-α. and leptin [18]. Conversely, 
leptin stimulates cytokine activation and 
immune-cell proliferation, an effect that 
predisposes to inﬂ  ammatory conditions 
[4]. Is it possible, then, that sleep-
related changes in leptin and ghrelin 
inﬂ  uence the development of metabolic 
and immune disorders? Can biologically 
restorative sleep reverse disease 
progression? Can biologically restorative 
sleep be deﬁ  ned on the basis of 
metabolic hormone responses? Future 
research may answer some of these and 
other questions, further elucidating the 
role of sleep in public health.  
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